Effects of Detached Mindfulness on Patients with Obsessive-Compulsive Disorder.
Murad Atmaca, Muhammed Fatih Tabara, Mehmet Gürkan Gürok
Alpha psychiatry January 1, 2024 DOI: 10.5152/alphapsychiatry.2024.231385
Summary
Detached mindfulness (DM) significantly reduced obsession levels in patients with obsessive-compulsive disorder (OCD). In a study involving 17 adults receiving medication, mean scores on the Yale-Brown Obsession Compulsion Scale dropped from 25.29 to 13.53 after treatment. The average homework completion rates across sessions remained high, indicating engagement with the DM technique. These findings suggest that DM can effectively alleviate symptoms in OCD patients, particularly those experiencing moderate severity, highlighting its potential as a valuable therapeutic approach.
Abstract
The objective of this study was to evaluate the effectiveness of detached mindfulness (DM) in patients with obsessive-compulsive disorder (OCD). Seventeen adult patients with OCD, who were receiving psychotropic medication, were included in the study. M.A., a qualified metacognitive therapist at the Metacognitive Therapy Institute in Manchester, conducted DM therapy. The Yale-Brown Obsession Compulsion Scale (Y-BOCS) and the Beck Depression Inventory (BDI) were used to monitor clinical progress. The mean Y-BOCS scores at baseline and the end of the study were 25.29 ± 5.70 and 13.53 ± 3.41, respectively, and a paired t-test analysis revealed a statistically significant difference between baseline and end-of-treatment scores (P<.001). The homework practices were also assessed in sessions 2, 3, and 4. The mean homework scores at the second, third, and fourth homework sessions were 8.70 ± 1.10, 8.00 ± 0.79 and 8.20 ± 1.1, respectively. The DM homework completion rate was at an acceptable level. In conclusion, our study has shown that the DM technique, one of the main techniques used in metacognitive therapy, is significantly beneficial in patients with a certain degree of severity. We are of the opinion that supportive studies with larger sample sizes are necessary for the demonstration of efficacy in patients with significant treatment resistance.